Company Filing History:
22 out of 378 
8 out of 721 
5 out of 192 
Years Active: 2007-2023
Title: Innovative Contributions of Ulrich Lücking in Pharmaceutical Patents
Introduction
Ulrich Lücking, based in Berlin, Germany, is a prominent inventor known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio featuring 38 patents, Lücking has cemented his reputation as a leading figure in the development of novel therapeutic compounds and innovative medical solutions.
Latest Patents
Among Ulrich Lücking's latest innovations are two notable patents. The first patent focuses on PTEFB inhibiting macrocyclic compounds. This invention details novel modified macrocyclic compounds characterized by an improved tolerability formula, aimed at the treatment and prevention of various disorders, particularly hyper-proliferative disorders and virally induced infectious diseases, as well as cardiovascular diseases. Additionally, the patent includes information on intermediate compounds essential for the synthesis of these macrocyclic compounds.
The second patent pertains to substituted 2-(morpholin-4-yl)-1,7-naphthyridine compounds. This invention outlines the preparation methods for these compounds, their associated pharmaceutical compositions, and their potential use in treating or preventing diseases, particularly hyperproliferative diseases. The compounds can be utilized alone or in combination with other active ingredients, highlighting their versatility in pharmaceutical applications.
Career Highlights
Ulrich Lücking's career has been marked by significant contributions to the pharmaceutical industry through his work at Bayer Pharma Aktiengesellschaft and Bayer Intellectual Property GmbH. His role in these esteemed organizations has allowed him to influence the development of innovative solutions in medicine, ensuring that his inventions not only advance scientific knowledge but also improve patient care.
Collaborations
Throughout his career, Lücking has collaborated with notable colleagues, including Gerhard Siemeister and Philip Lienau. These partnerships have facilitated the exchange of ideas and expertise, culminating in the successful development of numerous patents that demonstrate their collective commitment to medical advancements.
Conclusion
Ulrich Lücking's innovative spirit and dedication to research have established him as a key inventor in the pharmaceutical field. With a strong portfolio of patents and fruitful collaborations, he continues to contribute towards the advancement of medical treatments that benefit healthcare systems worldwide. Lücking's work serves as an inspiration to future inventors aiming to make their mark in the world of innovation and invention.